who's next on the HCV uber premium buyout gravy train? ACHN ,IDIX , FURX ?
What does FURX have in HCV?
i see Medivir has a phase3 in HCV, J&J partner i believe?
Though I really like Medivir, I doubt they'll be a buyout candidate given that they're already partnered with JNJ/Tibotec on TMC435 and their pre-clinical nuke.